Intra-Cellular Therapies Inc (NASDAQ:ITCI)

44.61
Delayed Data
As of Sep 27
 +1.91 / +4.47%
Today’s Change
34.43
Today|||52-Week Range
66.00
-14.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-104.8M-116.4M-97.8M-155.1M
 
 
 
 
 
Depreciation139.6K196.9K213.9K368.7K
 
 
 
 
 
Total Other Cash Flow11.8M15.5M15.3M16.6M
 
 
 
 
 
Funds From Operations-92.9M-100.8M-83.4M-137.6M
 
 
 
 
 
Funds From/For Other Operating Expenses9.4M-9.5M-2.9M-19.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-102.3M-91.3M-80.5M-118.2M
 
 
 
 
 
 
InvestingIncrease In Investments-514.3M-395.8M-520.9M-271.2M
 
 
 
 
 
Decrease In Investments153.4M488.1M428.9M406.2M
 
 
 
 
 
Capital Expenditures-860.6K-49.0K-723.4K-391.3K
 
 
 
 
 
Net Cash Flow Investing-361.8M92.3M-92.7M134.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale449.9M477.7K162.4M685.2K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing449.9M477.7K162.4M685.2K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-14.2M1.5M-10.9M17.2M